Akso Health (AHG) Receivables (2019 - 2025)

Akso Health has reported Receivables for 7 years, with the latest figure at $3.2 million in Q3 2025.

• For the quarter ending Q3 2025, Receivables rose 676.43% year-over-year to $3.2 million; the trailing twelve-month figure through Sep 2025 stood at $3.2 million (up 676.43% YoY), and the FY2025 full-year result was $8.6 million, up 10.99% from the prior year.
• Receivables for Q3 2025 stood at $3.2 million, up from $954200.0 in the prior quarter.
• The five-year high for Receivables was $17.8 billion in Q3 2021, with the low at $327186.0 in Q3 2023.
• Historically, Receivables has averaged $1.8 billion across 5 years, with a median of $7.8 million in 2022.
• Annual changes were most pronounced in 2021 — Receivables jumped 209509.61% — and 2022, when it slumped 99.96%.
• Akso Health's Receivables stood at $17.8 billion in 2021, then plunged by 99.96% to $7.9 million in 2022, then sank by 95.87% to $327186.0 in 2023, then advanced by 24.77% to $408234.0 in 2024, then jumped by 676.43% to $3.2 million in 2025.
• The last three Receivables figures came in at $3.2 million (Q3 2025), $954200.0 (Q1 2025), and $408234.0 (Q3 2024), per Business Quant data.